Q4 2023 update: private equity deals in pharmaceutical in Europe
In the European pharmaceutical industry, there were 21 private equity deals announced in Q4 2023, worth a total value of…
LGP4
-
-
Q4 2023 update: M&A activity in pharmaceutical in France
In the French pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $7.4bn,…
-
Q4 2023 update: private equity deals in pharmaceutical in Asia-Pacific
In the Asia-Pacific pharmaceutical industry, there were 10 private equity deals announced in Q4 2023, worth a total value of…
-
Q4 2023 update: M&A activity in pharmaceutical in Canada
In the Canadian pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $247m,…
-
Q4 2023 update: private equity deals in pharmaceutical in India
In the Indian pharmaceutical industry, there were 3 private equity deals announced in Q4 2023, worth a total value of…
-
Q4 2023 update: M&A activity in pharmaceutical in China
In the Chinese pharmaceutical industry, there were 29 M&A deals announced in Q4 2023, worth a total value of $3.5bn,…
-
How did M&A perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 426 M&A deals announced in Q4 2023, worth a total value of $84.2bn,…
-
Q4 2023 update: M&A activity in pharmaceutical in the US
In the US pharmaceutical industry, there were 210 M&A deals announced in Q4 2023, worth a total value of $64.6bn,…
-
Q4 2023 update: M&A activity in pharmaceutical in Middle East and Africa
In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total…
-
Q4 2023 update: M&A activity in pharmaceutical in Italy
In the Italian pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $6.9bn,…